Compound has potential for new class of AIDS drugs

User rating: 5 / 5 after 6 vote(s)

Researchers have developed what they believe is the first new mechanism in nearly 20 years for inhibiting a common target used to treat all HIV patients, which could eventually lead to a new class of AIDS drugs.


Full story »
All News summaries from Medicine & Health news
All News summaries for May 14, 2008

New treatment approach promising for lymphoma patients in the developing world

4 hours ago | User rating: not rated yet
Preliminary results suggest that patients with aggressive non-Hodgkin's lymphoma in the developing world might benefit from a modified chemotherapy regimen, researchers say.

Counting tumor cells in blood predicts treatment benefit in prostate cancer

4 hours ago | User rating: not rated yet
Counting the number of tumor cells circulating in the bloodstream of patients with castration-resistant prostate cancer can accurately predict how well they are responding to treatment, new results show.

Treatment delays result in poor outcomes for men with breast cancer

4 hours ago | User rating: not rated yet
Men who develop breast cancer are often not treated until the disease has spread to the point that treatment becomes difficult, new results show.

Surrogate children are psychologically well: study

7 hours ago | User rating: not rated yet
Children born to a surrogate mother or conceived through donated sperm or a donated egg do just as well psychologically as counterparts who are naturally conceived, a study unveiled on Sunday said.

Topical oral syrup prevents early childhood caries

Jul 05, 2008 | User rating: not rated yet
Dental researchers at the University of Washington have reported a significant reduction of tooth decay in toddlers who were treated with the topical syrup xylitol, a naturally occurring non-cavity-causing sweetener. Their ...
Goto Archive PhysOrg Forum Goto Archive Video Goto Archive Editorials Goto Archive Free Magazines Goto Archive Newsletter

News Archive